Similar articles for PMID: 22479369

Year	Number of Results
2001	2
2002	1
2003	3
2004	4
2005	2
2006	6
2007	6
2008	5
2009	10
2010	15
2011	15
2012	24
2013	15
2014	21
2015	15
2016	10
2017	12
2018	5
2019	4
2020	3
2021	6
2022	4
2023	7
2024	0

1

Effect of polymorphisms in XPD on clinical outcomes of platinum-based chemotherapy for Chinese non-small cell lung cancer patients.

Wu W, Li H, Wang H, Zhao X, Gao Z, Qiao R, Zhang W, Qian J, Wang J, Chen H, Wei Q, Han B, Lu D. Wu W, et al. PLoS One. 2012;7(3):e33200. doi: 10.1371/journal.pone.0033200. Epub 2012 Mar 29. PLoS One. 2012. PMID: 22479369 Free PMC article. Clinical Trial.

2

Association of XPD polymorphisms with severe toxicity in non-small cell lung cancer patients in a Chinese population.

Wu W, Zhang W, Qiao R, Chen D, Wang H, Wang Y, Zhang S, Gao G, Gu A, Shen J, Qian J, Fan W, Jin L, Han B, Lu D. Wu W, et al. Clin Cancer Res. 2009 Jun 1;15(11):3889-95. doi: 10.1158/1078-0432.CCR-08-2715. Epub 2009 May 19. Clin Cancer Res. 2009. PMID: 19458053

3

Association between polymorphisms of BAG-1 and XPD and chemotherapy sensitivity in advanced non-small-cell lung cancer patients treated with vinorelbine combined cisplatin regimen.

Li P, Wang YD, Cheng J, Chen JC, Ha MW. Li P, et al. Tumour Biol. 2015 Dec;36(12):9465-73. doi: 10.1007/s13277-015-3672-z. Epub 2015 Jun 30. Tumour Biol. 2015. PMID: 26124006

4

Correlation of DNA Repair Gene Polymorphisms With Clinical Outcome in Patients With Locally Advanced Non-Small-Cell Lung Cancer Receiving Induction Chemotherapy Followed by Surgery.

Santarpia M, Ramirez JL, de Aguirre I, Garrido P, Pérez Cano M, Queralt C, Gonzalez-Larriba JL, Insa A, Provencio M, Isla D, Camps C, Blanco R, Moran T, Rosell R; Spanish Lung Cancer Group. Santarpia M, et al. Clin Lung Cancer. 2017 Mar;18(2):178-188.e4. doi: 10.1016/j.cllc.2016.08.007. Epub 2016 Nov 9. Clin Lung Cancer. 2017. PMID: 27908619

5

Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients.

Tibaldi C, Giovannetti E, Vasile E, Mey V, Laan AC, Nannizzi S, Di Marsico R, Antonuzzo A, Orlandini C, Ricciardi S, Del Tacca M, Peters GJ, Falcone A, Danesi R. Tibaldi C, et al. Clin Cancer Res. 2008 Mar 15;14(6):1797-803. doi: 10.1158/1078-0432.CCR-07-1364. Clin Cancer Res. 2008. PMID: 18347182

6

Assessment of XPD Lys751Gln and XRCC1 T-77C polymorphisms in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy.

Liu L, Yuan P, Wu C, Zhang X, Wang F, Guo H, Zhong R, Xu Y, Wu J, Yu D, Wu T, Zhang X, Nie S, Miao X, Lin D. Liu L, et al. Lung Cancer. 2011 Jul;73(1):110-5. doi: 10.1016/j.lungcan.2010.11.004. Epub 2010 Dec 3. Lung Cancer. 2011. PMID: 21129812

7

Predictive effect of XPA and XPD polymorphisms on survival of advanced NSCLC patients treated with platinum-based chemotherapy: a three-dimensional (3-D), polyacrylamide gel-based DNA microarray method.

Cheng H, Qin Q, Sun X, Li F, Sun N, Cheng L, Lu Z, Chen B. Cheng H, et al. Technol Cancer Res Treat. 2013 Oct;12(5):473-82. doi: 10.7785/tcrt.2012.500337. Epub 2013 Apr 24. Technol Cancer Res Treat. 2013. PMID: 23617284 Free article.

8

Lack of influence of XRCC1 and XPD gene polymorphisms on outcome of platinum-based chemotherapy for advanced non small cell lung cancers.

Yao CY, Huang XE, Li C, Shen HB, Shi MQ, Feng JF, Pan LX, Tang JH. Yao CY, et al. Asian Pac J Cancer Prev. 2009;10(5):859-64. Asian Pac J Cancer Prev. 2009. PMID: 20104979 Free article.

9

Association of xeroderma pigmentosum group D (Asp312Asn, Lys751Gln) and cytidine deaminase (Lys27Gln, Ala70Thr) polymorphisms with outcome in Chinese non-small cell lung cancer patients treated with cisplatin-gemcitabine.

Zhou M, Ding YJ, Feng Y, Zhang QR, Xiang Y, Wan HY. Zhou M, et al. Genet Mol Res. 2014 Apr 29;13(2):3310-8. doi: 10.4238/2014.April.29.9. Genet Mol Res. 2014. PMID: 24841663 Free article.

10

[Correlation of genetic polymorphisms in nucleotide excision repair system to sensitivity of advanced non-small cell lung cancer patients to platinum-based chemotherapy].

Yuan P, Miao XP, Zhang XM, Wang ZH, Tan W, Zhang XR, Sun Y, Xu BH, Lin DX. Yuan P, et al. Ai Zheng. 2005 Dec;24(12):1510-3. Ai Zheng. 2005. PMID: 16351803 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

168 results

Results by year